Patents Assigned to Lachesis Biosciences Limited
  • Intranasal compositions for treatment of neurological and neurodegenerative diseases and disorders
    Patent number: 11911360
    Abstract: The present invention relates generally to intranasal pharmaceutical compositions. In particular, the present invention is directed to sustained, enhanced delivery of pharmaceutical agents across the nasal mucosa for systemic drug delivery.
    Type: Grant
    Filed: January 27, 2021
    Date of Patent: February 27, 2024
    Assignee: Lachesis Biosciences Limited
    Inventor: Timothy Matthias Morgan
  • Intranasal compositions for treatment of neurological and neurodegenerative diseases and disorders
    Patent number: 10933045
    Abstract: The present invention relates generally to intranasal pharmaceutical compositions. In particular, the present invention is directed to sustained, enhanced delivery of pharmaceutical agents across the nasal mucosa for systemic drug delivery.
    Type: Grant
    Filed: September 13, 2019
    Date of Patent: March 2, 2021
    Assignee: LACHESIS BIOSCIENCES LIMITED
    Inventor: Timothy Matthias Morgan
  • Intranasal compositions for treatment of neurological and neurodegenerative diseases and disorders
    Patent number: 10471040
    Abstract: The present invention relates generally to intranasal pharmaceutical compositions. In particular, the present invention is directed to sustained, enhanced delivery of pharmaceutical agents across the nasal mucosa for systemic drug delivery.
    Type: Grant
    Filed: September 30, 2015
    Date of Patent: November 12, 2019
    Assignee: Lachesis Biosciences Limited
    Inventor: Timothy Matthias Morgan